Investigation of ovarian neoplasia of low malignant potential for human papillomavirus

Robert McLellan, J. Buscema, E. Guerrero, K. V. Shah, J. D. Woodruff, J. L. Currie

Research output: Contribution to journalArticle

Abstract

Recent in situ hybridization studies have suggested the presence of human papillomavirus type 6 (HPV-6) DNA in ovarian cancer cells. An association between HPV and ovarian neoplasia of low malignant potential (LMP) has not been previously identified. Paraffin-embedded tissue blocks from 24 patients with LMP ovarian tumors were screened for human papillomavirus DNA. The patients ranged in age from 18 to 73 years. Corresponding microscopic slides from each tissue block were reviewed to confirm the histopathologic diagnosis. For identification of HPV genome, deparaffinized sections were subjected to the polymerase chain reaction to achieve amplification of DNAs of HPV types 6, 11, 16, and 18. For each HPV type, a 120-base-pair region of the E6 gene was targeted for amplification. Human papillomaviral DNA was not detected in the tissue specimens subjected to polymerase chain reaction. These results suggest that HPV types 6, 11, 16, and 18 are not likely to play a role in LMP ovarian tumors. These results do not totally exclude possible contributions of other HPV types.

Original languageEnglish (US)
Pages (from-to)383-385
Number of pages3
JournalGynecologic Oncology
Volume38
Issue number3
DOIs
StatePublished - 1990

Fingerprint

Human papillomavirus 6
Human papillomavirus 11
DNA
Neoplasms
Polymerase Chain Reaction
Base Pairing
Paraffin
Ovarian Neoplasms
In Situ Hybridization
Genome
Genes

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

McLellan, R., Buscema, J., Guerrero, E., Shah, K. V., Woodruff, J. D., & Currie, J. L. (1990). Investigation of ovarian neoplasia of low malignant potential for human papillomavirus. Gynecologic Oncology, 38(3), 383-385. https://doi.org/10.1016/0090-8258(90)90078-Y

Investigation of ovarian neoplasia of low malignant potential for human papillomavirus. / McLellan, Robert; Buscema, J.; Guerrero, E.; Shah, K. V.; Woodruff, J. D.; Currie, J. L.

In: Gynecologic Oncology, Vol. 38, No. 3, 1990, p. 383-385.

Research output: Contribution to journalArticle

McLellan, R, Buscema, J, Guerrero, E, Shah, KV, Woodruff, JD & Currie, JL 1990, 'Investigation of ovarian neoplasia of low malignant potential for human papillomavirus', Gynecologic Oncology, vol. 38, no. 3, pp. 383-385. https://doi.org/10.1016/0090-8258(90)90078-Y
McLellan, Robert ; Buscema, J. ; Guerrero, E. ; Shah, K. V. ; Woodruff, J. D. ; Currie, J. L. / Investigation of ovarian neoplasia of low malignant potential for human papillomavirus. In: Gynecologic Oncology. 1990 ; Vol. 38, No. 3. pp. 383-385.
@article{5ad71851a14b4deea0c5d4857b44ed5b,
title = "Investigation of ovarian neoplasia of low malignant potential for human papillomavirus",
abstract = "Recent in situ hybridization studies have suggested the presence of human papillomavirus type 6 (HPV-6) DNA in ovarian cancer cells. An association between HPV and ovarian neoplasia of low malignant potential (LMP) has not been previously identified. Paraffin-embedded tissue blocks from 24 patients with LMP ovarian tumors were screened for human papillomavirus DNA. The patients ranged in age from 18 to 73 years. Corresponding microscopic slides from each tissue block were reviewed to confirm the histopathologic diagnosis. For identification of HPV genome, deparaffinized sections were subjected to the polymerase chain reaction to achieve amplification of DNAs of HPV types 6, 11, 16, and 18. For each HPV type, a 120-base-pair region of the E6 gene was targeted for amplification. Human papillomaviral DNA was not detected in the tissue specimens subjected to polymerase chain reaction. These results suggest that HPV types 6, 11, 16, and 18 are not likely to play a role in LMP ovarian tumors. These results do not totally exclude possible contributions of other HPV types.",
author = "Robert McLellan and J. Buscema and E. Guerrero and Shah, {K. V.} and Woodruff, {J. D.} and Currie, {J. L.}",
year = "1990",
doi = "10.1016/0090-8258(90)90078-Y",
language = "English (US)",
volume = "38",
pages = "383--385",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Investigation of ovarian neoplasia of low malignant potential for human papillomavirus

AU - McLellan, Robert

AU - Buscema, J.

AU - Guerrero, E.

AU - Shah, K. V.

AU - Woodruff, J. D.

AU - Currie, J. L.

PY - 1990

Y1 - 1990

N2 - Recent in situ hybridization studies have suggested the presence of human papillomavirus type 6 (HPV-6) DNA in ovarian cancer cells. An association between HPV and ovarian neoplasia of low malignant potential (LMP) has not been previously identified. Paraffin-embedded tissue blocks from 24 patients with LMP ovarian tumors were screened for human papillomavirus DNA. The patients ranged in age from 18 to 73 years. Corresponding microscopic slides from each tissue block were reviewed to confirm the histopathologic diagnosis. For identification of HPV genome, deparaffinized sections were subjected to the polymerase chain reaction to achieve amplification of DNAs of HPV types 6, 11, 16, and 18. For each HPV type, a 120-base-pair region of the E6 gene was targeted for amplification. Human papillomaviral DNA was not detected in the tissue specimens subjected to polymerase chain reaction. These results suggest that HPV types 6, 11, 16, and 18 are not likely to play a role in LMP ovarian tumors. These results do not totally exclude possible contributions of other HPV types.

AB - Recent in situ hybridization studies have suggested the presence of human papillomavirus type 6 (HPV-6) DNA in ovarian cancer cells. An association between HPV and ovarian neoplasia of low malignant potential (LMP) has not been previously identified. Paraffin-embedded tissue blocks from 24 patients with LMP ovarian tumors were screened for human papillomavirus DNA. The patients ranged in age from 18 to 73 years. Corresponding microscopic slides from each tissue block were reviewed to confirm the histopathologic diagnosis. For identification of HPV genome, deparaffinized sections were subjected to the polymerase chain reaction to achieve amplification of DNAs of HPV types 6, 11, 16, and 18. For each HPV type, a 120-base-pair region of the E6 gene was targeted for amplification. Human papillomaviral DNA was not detected in the tissue specimens subjected to polymerase chain reaction. These results suggest that HPV types 6, 11, 16, and 18 are not likely to play a role in LMP ovarian tumors. These results do not totally exclude possible contributions of other HPV types.

UR - http://www.scopus.com/inward/record.url?scp=0025186468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025186468&partnerID=8YFLogxK

U2 - 10.1016/0090-8258(90)90078-Y

DO - 10.1016/0090-8258(90)90078-Y

M3 - Article

C2 - 2172118

AN - SCOPUS:0025186468

VL - 38

SP - 383

EP - 385

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -